Extreme Genetic Fragility of the HIV-1 Capsid

Suzannah J. Rihn, Sam J. Wilson, Nick J. Loman, Mudathir Alim, Saskia E. Bakker, David Bhella, Robert J. Gifford, Frazer J. Rixon, Paul D. Bieniasz

Research output: Contribution to journalArticlepeer-review

117 Citations (Scopus)

Abstract

Genetic robustness, or fragility, is defined as the ability, or lack thereof, of a biological entity to maintain function in the face of mutations. Viruses that replicate via RNA intermediates exhibit high mutation rates, and robustness should be particularly advantageous to them. The capsid (CA) domain of the HIV-1 Gag protein is under strong pressure to conserve functional roles in viral assembly, maturation, uncoating, and nuclear import. However, CA is also under strong immunological pressure to diversify. Therefore, it would be particularly advantageous for CA to evolve genetic robustness. To measure the genetic robustness of HIV-1 CA, we generated a library of single amino acid substitution mutants, encompassing almost half the residues in CA. Strikingly, we found HIV-1 CA to be the most genetically fragile protein that has been analyzed using such an approach, with 70% of mutations yielding replication-defective viruses. Although CA participates in several steps in HIV-1 replication, analysis of conditionally (temperature sensitive) and constitutively non-viable mutants revealed that the biological basis for its genetic fragility was primarily the need to coordinate the accurate and efficient assembly of mature virions. All mutations that exist in naturally occurring HIV-1 subtype B populations at a frequency >3%, and were also present in the mutant library, had fitness levels that were >40% of WT. However, a substantial fraction of mutations with high fitness did not occur in natural populations, suggesting another form of selection pressure limiting variation in vivo. Additionally, known protective CTL epitopes occurred preferentially in domains of the HIV-1 CA that were even more genetically fragile than HIV-1 CA as a whole. The extreme genetic fragility of HIV-1 CA may be one reason why cell-mediated immune responses to Gag correlate with better prognosis in HIV-1 infection, and suggests that CA is a good target for therapy and vaccination strategies.

Original languageEnglish
Article numbere1003461
JournalPLoS Pathogens
Volume9
Issue number6
DOIs
Publication statusPublished - Jun 2013
Externally publishedYes

Bibliographical note

Funding Information:
We thank Theodora Hatziioannou for review of the manuscript and members of the Bieniasz Laboratory for reagents and advice. We also thank Ian Salt for thoughtful advice and for the use of a LiCOR infrared imaging system made possible by support from Diabetes UK to Ian Salt and colleagues at the University of Glasgow. The following reagents were obtained through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: hybridoma 183-H12-5C (#1513) from Bruce Chesebro, antiserum to p17 (# 4811) from Paul Spearman and pNL4-3 (# 114) from Malcolm Martin.

Fingerprint

Dive into the research topics of 'Extreme Genetic Fragility of the HIV-1 Capsid'. Together they form a unique fingerprint.

Cite this